Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Tables)

Basis of Presentation and Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Basic and Diluted Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per common share (in thousands, except per share amounts) for the three months ended:

	March 31, 2021			March 31, 2020
Numerator:
Net income (loss) attributable to common stockholders	$	(2,738	)	$	(1,990	)
Denominator:
Weighted average number of shares outstanding, basic		71,248			41,662
Adjustment for dilutive effects of warrants, outstanding and in-the-money		-			-
Adjustment for dilutive effects of options, exercisable and in-the-money		15			-
Weighted average number of common shares outstanding, diluted		71,263			41,662
Net income (loss) per common share, basic	$	(0.04	)	$	(0.05	)
Net income (loss) per common share, diluted	$	(0.04	)	$	(0.05	)

Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share

The following table sets forth the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive (in thousands):

	March 31,
	2021		2020
Outstanding options to purchase common stock		1,772		923
Warrants to purchase common stock		243		243
Notes payable convertible to common stock		-		-
Total		2,015		1,166